XML 68 R58.htm IDEA: XBRL DOCUMENT
v3.22.2

REVENUES - Net Sales from Contracts with Customers by Global Business Unit (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | $ 3,746 | $ 3,098 | $ 7,453 | $ 6,044
U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 1,764 | 1,198 | 3,521 | 2,378
International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 1,982 | 1,900 | 3,932 | 3,666
Renal Care |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 931 | 964 | 1,825 | 1,886
Renal Care | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 225 | 217 | 450 | 433
Renal Care | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 706 | 747 | 1,375 | 1,453
Medication Delivery |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 710 | 697 | 1,416 | 1,349
Medication Delivery | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 459 | 444 | 931 | 855
Medication Delivery | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 251 | 253 | 485 | 494
Pharmaceuticals |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 528 | 546 | 1,049 | 1,098
Pharmaceuticals | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 164 | 162 | 321 | 362
Pharmaceuticals | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 364 | 384 | 728 | 736
Clinical Nutrition |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 230 | 237 | 457 | 471
Clinical Nutrition | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 90 | 84 | 174 | 167
Clinical Nutrition | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 140 | 153 | 283 | 304
Advanced Surgery |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 263 | 256 | 491 | 473
Advanced Surgery | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 151 | 144 | 287 | 270
Advanced Surgery | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 112 | 112 | 204 | 203
Acute Therapies |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 173 | 188 | 361 | 395
Acute Therapies | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 58 | 61 | 126 | 142
Acute Therapies | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 115 | 127 | 235 | 253
BioPharma Solutions |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 163 | 183 | 319 | 318
BioPharma Solutions | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 75 | 65 | 127 | 109
BioPharma Solutions | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 88 | 118 | 192 | 209
Patient Support Systems |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 364 | 0 | 747 | 0
Patient Support Systems | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 284 | 0 | 579 | 0
Patient Support Systems | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 80 | 0 | 168 | 0
Front Line Care |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 282 | 0 | 576 | 0
Front Line Care | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 202 | 0 | 409 | 0
Front Line Care | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 80 | 0 | 167 | 0
Surgical Solutions |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 69 | 0 | 147 | 0
Surgical Solutions | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 36 | 0 | 73 | 0
Surgical Solutions | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 33 | 0 | 74 | 0
Other |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 33 | 27 | 65 | 54
Other | U.S. |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | 20 | 21 | 44 | 40
Other | International |  |  |  |
Revenue From Contract With Customer [Line Items] |  |  |  |
Net sales | $ 13 | $ 6 | $ 21 | $ 14

X
- Definition Revenue from contract with customer. + References No definition available. + Details
Name: | bax_RevenueFromContractWithCustomerLineItems
Namespace Prefix: | bax_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_RenalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_MedicationDeliveryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_PharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_ClinicalNutritionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_AdvancedSurgeryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_AcuteTherapiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_BioPharmaSolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_PatientSupportSystemsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_FrontLineCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_SurgicalSolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bax_OtherProductOrServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |